Genital wart coding: E/M code is likely your best bet

Why This Topic Matters

Genital wart claims can be difficult to code consistently when the documented treatment method does not fit neatly into a procedure code family. Understanding the scope of CPT guidance helps coding professionals avoid mismatches between documentation and reported service category.

Article Sections

1. Topical chemotherapy and office visit reporting

   Introduces the documentation scenario and summarizes the CPT guidance that directs reporting toward office visits for topical chemotherapy care. The section frames the coding issue within lesion treatment and integumentary guidance.

2. Comparison of genital lesion destruction code families

   Reviews how genital lesion destruction is represented across female and male genital system code families and why the article says the reporting question is not straightforward. The section compares the broader categories of treatment addressed by these code families.

3. Conflicting CPT guidance and the term chemosurgery

   Explains the source of confusion created by the term chemosurgery and the way CPT references it in multiple places. The section discusses the apparent inconsistency between code language and guideline language.